Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 320

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease

Open access
Lewis, James D., Sandler, Robert S., Brotherton, Carol, Brensinger, Colleen, Li, Hongzhe, Kappelman, Michael D., Daniel, Scott G., Bittinger, Kyle, Albenberg, Lindsey, Valentine, John F., Hanson, John S., Suskind, David L., Meyer, Andrea, Compher, Charlene W., Bewtra, Meenakshi, Saxena, Akriti, Dobes, Angela, Cohen, Benjamin L., Flynn, Ann D., Fischer, Monika, Saha, Sumona, Swaminath, Arun, Yacyshyn, Bruce, Scherl, Ellen, Horst, Sara, Curtis, Jeffrey R., Braly, Kimberly, Nessel, Lisa, McCauley, Maureen, McKeever, Liam, Herfarth, Hans · 2021 · Gastroenterology

Abstract

Background & Aims: This study compared the effectiveness of the Specific Carbohydrate Diet (SCD) to the Mediterranean Diet (MD) as treatment for Crohn’s disease (CD) with mild to moderate symptoms. Methods: Adult patients with CD and with mild-moderate symptoms were randomly assigned 1:1 to consume the MD or SCD for 12 weeks. For the first 6-weeks, participants received prepared meals and snacks according to their assigned diet. After 6-weeks, participants were instructed to follow the diet independently. The primary outcome was symptomatic remission at week 6. Key secondary outcomes at week 6 included: fecal calprotectin (FC) response (FC <250 μg/g and reduction by >50% among those with baseline FC >250 μg/g) and C-Reactive Protein (CRP) response (high-sensitivity CRP (hsCRP) <5 mg/L and >50% reduction from baseline among those with hsCRP >5mg/L). Results: 194 patients were randomized, and 191 were included in the efficacy analyses. The percentage of participants who achieved symptomatic remission at week 6 was not superior with SCD (SCD 46.5%, MD 43.5%; P = .77). FC response was achieved in 8/23 participants (34.8%) with SCD and 4/13 participants (30.8%) with MD (P = .83). CRP response was achieved in 2/37 participants (5.4%) with SCD and 1/28 participant (3.6%) with MD (P = .68). Conclusions: SCD was not superior to MD to achieve symptomatic remission, FC response and CRP response. CRP response was uncommon. Given these results, the greater ease of following the MD, and other health benefits associated with MD, the MD may be preferred to the SCD for most patients with CD with mild to moderate symptoms. ClinicalTrials.gov Identifier: NCT03058679

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2021.05.047

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 47 references

Cited by

See all 320

Metadata

Authors
Lewis, J. D., Sandler, R. S., Brotherton, C., Brensinger, C., Li, H., Kappelman, M. D., Daniel, S. G., Bittinger, K., Albenberg, L., Valentine, J. F., Hanson, J. S., Suskind, D. L., Meyer, A., Compher, C. W., Bewtra, M., Saxena, A., Dobes, A., Cohen, B. L., Flynn, A. D., Fischer, M., Saha, S., Swaminath, A., Yacyshyn, B., Scherl, E., Horst, S., Curtis, J. R., Braly, K., Nessel, L., McCauley, M., McKeever, L., & Herfarth, H.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2021-09
Volume
161
Issue
3
Pages
837-852.e9
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3165463838
Cited by
320
References
47
FWCI
23.16
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease. https://app.cochat.ai/papers/10.1053/j.gastro.2021.05.047
The paper
Lewis, J. D., Sandler, R. S., Brotherton, C., Brensinger, C., Li, H., Kappelman, M. D., Daniel, S. G., Bittinger, K., Albenberg, L., Valentine, J. F., Hanson, J. S., Suskind, D. L., Meyer, A., Compher, C. W., Bewtra, M., Saxena, A., Dobes, A., Cohen, B. L., Flynn, A. D., . . . Herfarth, H. (2021). A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn’s Disease. Gastroenterology. https://doi.org/10.1053/j.gastro.2021.05.047

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.